Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Metropolis Healthcare Ltd.
Change Company   
BSE Code 542650
ISIN Demat INE112L01020
Book Value 240.23
NSE Code METROPOLIS
Dividend Yield % 0.00
Market Cap 91891.35
P/E 73.63
EPS 24.09
Face Value 2  
02-Jul-2025 Metropolis Healthcare informs about disclosure
20-Jun-2025 Announcement under Regulation 30 (LODR)-Change i...
18-Jun-2025 Metropolis Healthcare rises as its arm acquires e...
17-Jun-2025 Metropolis Healthcare’s arm acquires entire busin...
17-Jun-2025 Metropolis Healthcare informs about updates on ac...
31-May-2025 Metropolis Healthcare submits analyst meet intima...
24-May-2025 Metropolis Healthcare informs about disclosure
07-Apr-2025 Metropolis Healthcare’s arm to acquire Dehradun’s...
07-Apr-2025 Metropolis Healthcare informs about disclosure
28-Mar-2025 Metropolis Healthcare informs about disclosure
24-Mar-2025 Metropolis Healthcare acquires Core Diagnostics
24-Mar-2025 Metropolis Healthcare rises on acquiring Core Dia...
22-Mar-2025 Metropolis Healthcare informs about updates on ac...
17-Mar-2025 Metropolis Healthcare informs about grant of rest...
03-Mar-2025 Metropolis Healthcare’s arm to acquire Agra-based...
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.